Difference between revisions of "CT Angiography Biomarker Ctte"
| (6 intermediate revisions by the same user not shown) | |||
| Line 10: | Line 10: | ||
*[[Media: 2019 01 14 QIBA CT Angiography_FINAL.pdf | January 14, 2019]] | *[[Media: 2019 01 14 QIBA CT Angiography_FINAL.pdf | January 14, 2019]] | ||
*[[Media: 2018 12 17 QIBA CT Angiography_FINAL.pdf | December 17, 2018]] | *[[Media: 2018 12 17 QIBA CT Angiography_FINAL.pdf | December 17, 2018]] | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
'''''[[CT Angiography Call Summaries Archive]]''''' | '''''[[CT Angiography Call Summaries Archive]]''''' | ||
| Line 30: | Line 22: | ||
==Profile Development== | ==Profile Development== | ||
| + | *[[Media:Atherosclerosis_Biomarkers_Profile_2019-02-11.docx | QIBA Atherosclerosis Biomarkers Profile Draft | February 11, 2019]] | ||
*[[Media:2019_01-31_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | January 31, 2019]] | *[[Media:2019_01-31_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | January 31, 2019]] | ||
*[[Media:2019_01-14_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | January 14, 2019]] | *[[Media:2019_01-14_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | January 14, 2019]] | ||
*[[Media:2018_12-17_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | December 17, 2018]] | *[[Media:2018_12-17_Atherosclerosis_Biomarkers_Profile-DRAFT.docx | QIBA Atherosclerosis Biomarkers Profile Draft | December 17, 2018]] | ||
| − | + | ||
| − | + | '''''[[Atherosclerosis Biomarkers Profile Draft Archive]]''''' | |
| − | + | ||
| − | |||
==Groundwork Projects== | ==Groundwork Projects== | ||
| − | |||
==Reference Materials== | ==Reference Materials== | ||
Revision as of 18:44, 11 February 2019
Co-chairs: Andrew Buckler, MS; Luca Saba, MD; Uwe Joseph Schoepf, MD, FAHA, FSCBT-MR, FNASCI, FSCCT Secretary: Julie Lisiecki
Meetings
Recent Call Summaries:
CT Angiography Call Summaries Archive
Project Snapshot - CT Angiography
The group intends to pursue writing quantitative profiles for both Coronary computed tomography angiography (CCTA) and CT angiography (CTA).
Excerpt from the biomarker committee submission form:
The QIBA Atherosclerosis Biomarkers Committee (ABC) is organized to document quantitative profiles for both Computed Tomography Angiography (CTA) and Coronary CTA (CCTA). The membership is composed of participants from multiple centers of excellence within North America and Europe utilizing different CTA vendors, acquisitions and scanner types, and analysis software vendors. Representatives from different manufacturers are included in the committee, who are interested in working closely with the committee in optimizing imaging biomarkers for scientific trials and clinical routine use. The Biomarker Committee develops technical performance standards to serve as atherosclerosis compositional biomarkers, engaging stakeholders from different societies, in addition to the RSNA, for example ASNR, SCCT, ACR, etc.
Profile Development
- QIBA Atherosclerosis Biomarkers Profile Draft | February 11, 2019
- QIBA Atherosclerosis Biomarkers Profile Draft | January 31, 2019
- QIBA Atherosclerosis Biomarkers Profile Draft | January 14, 2019
- QIBA Atherosclerosis Biomarkers Profile Draft | December 17, 2018
Atherosclerosis Biomarkers Profile Draft Archive
Groundwork Projects
Reference Materials
- QIBA Biomarkers Selection Criteria Atherosclerosis Biomarker Committee (ABC) {Mr. Buckler} March 27, 2018 (PDF)